Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Natural Remedies

World Health Assembly Forced To Postpone Decision On Viral Hepatitis
On the second annual World Hepatitis Day, the World Hepatitis Alliance today called on governments not to forget the plight of 500 million people living with hepatitis B and C, as the World Health Assembly postpones discussion of a World Health Organization (WHO) resolution on viral hepatitis - one of the biggest threats to global health.
generic viagra online
Houston Effort Seeks To Screen 15,000 Young Adults For HIV
The Houston Department of Health and Human Services, along with several community health agencies, over the next three weeks is seeking to test 15,000 young adults for HIV as part of an effort to commemorate National HIV Testing Day on June 27, the Houston Chronicle reports. To encourage people to participate, those who take the test and receive their results and one hour of HIV education will get free tickets to a local hip-hop concert. A similar effort last year tested 2,700 young adults in two weeks, and roughly 7,500 were screened over seven weeks in 2007. Combined, the 2007 and 2008 efforts identified about 50 people with the virus, according to the Chronicle (George, Houston Chronicle, 6/21).
News of the day
EMEA Grants Clinuvel New Orphan Drug - For Solar Urticaria - Designation
Clinuvel Pharmaceuticals Limited (ASX: CUV; XETRA-DAX: UR9; ADR: CLVLY) is pleased to announce that afamelanotide, its photoprotective drug, has been granted Orphan Medicinal Product (OMP) designation by the European Medicines Agency (EMEA) for the treatment of Solar Urticaria (SU). The EMEA granted afamelanotide its first OMP designation in March 2008 for the treatment of Erythropoietic Protoporphyria (EPP), Clinuvel"s lead indication currently in Phase III clinical trials.
Mental Health

Rhode Island Dept. Of Health Applauds New Tobacco Law, USA

The Rhode Island Department of Health (HEALTH) recognizes and applauds the significant public health achievement of The Family Smoking Prevention and Tobacco Control Act being signed into law. This new law gives the U.S. Food and Drug Administration (FDA) the authority to regulate tobacco products. "This is a major milestone in the tobacco control movement," said Director of Health David R. Gifford, MD, MPH. "This legislation will allow the FDA to enforce stricter guidelines regarding tobacco advertising and promotions - especially to children. Every year in Rhode Island, 1,400 children and teens become regular smokers. Many of these kids will die prematurely as a result of smoking. This law will help make it harder for youth to start smoking and make it easier for them to be a non-smoker." Each year, tobacco use kills more than 1,600 adult smokers in the state and 1,500 adult non-smokers due to the effects of exposure to second-hand smoke. Tobacco costs the state $506 million annually in healthcare-related costs. Rhode Island is the seventh state in the nation to go smoke-free and currently has the highest cigarette excise tax in the country at $3.46/pack. The new law will allow the FDA to regulate many aspects of the tobacco industry, including: ò€¢ Ban of candy and fruit-flavored cigarettes ò€¢ Requirement of large, graphic health warnings that cover the top half of the front and back of cigarette packs ò€¢ Ban of misleading health claims such as "light" or "low-tar" ò€¢ Disclose of the contents of tobacco products, as well as changes in products and research about their health effects. Rhode Island Department of Health


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009